High-purity GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide widely investigated in preclinical endocrine and receptor-binding research. Laboratory investigators seeking to source GHRP-2 must prioritize analytical verification, lot traceability, and chemical purity. PX1 Research provides USA-manufactured GHRP-2 verified by high-performance liquid chromatography (HPLC) and mass spectrometry for reliable assay reproducibility.
High-purity GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide widely investigated in preclinical endocrine and receptor-binding research. Laboratory investigators seeking to source GHRP-2 must prioritize analytical verification, lot traceability, and chemical purity. PX1 Research provides USA-manufactured GHRP-2 verified by high-performance liquid chromatography (HPLC) and mass spectrometry for reliable assay reproducibility.
Investigators inquiring about how to buy or procure GHRP-2 (often searched internationally as GHRP-2 peptide kopen) for experimental applications must evaluate suppliers based on rigorous quality assurance protocols rather than consumer marketing. GHRP-2 (D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2) is a synthetic growth-hormone secretagogue categorized strictly as a research compound intended for in vitro assays, cell culture models, and preclinical animal studies.
Acquiring reliable GHRP-2 research compounds requires strict verification of chemical identity, sequence integrity, and freedom from biological contamination. Qualified research institutions, university laboratories, and private research entities should demand lot-specific documentation prior to incorporating secretagogue compounds into active experimental protocols. PX1 Research manufactures research peptides within GMP-compliant USA facilities, backing each batch with independent testing from ISO 17025 accredited laboratories.
GHRP-2, also known in scientific literature as Pralmorelin, is an unnatural synthetic hexapeptide with the molecular formula C45H55N9O6 and a molecular weight of 818.0 atomic mass units (Da). Its specific amino acid sequence incorporates D-conformation amino acids—specifically D-beta-naphthylalanine and D-phenylalanine—which confer enzymatic resistance against systemic peptidases and endopeptidases during preclinical in vitro testing.
The inclusion of unnatural D-amino acids structurally stabilizes the molecule, preventing rapid proteolytic degradation in plasma matrices. This structural optimization allows researchers to observe prolonged receptor occupancy times when assessing signaling cascades in cell-based assays. In solid-state chemical form, GHRP-2 presents as a white, lyophilized powder that requires specific storage temperatures and reconstituted handling to preserve peptide bond stability over extended experimental timelines.
GHRP-2 functions primarily as a potent agonist at the growth hormone secretagogue receptor type 1a (GHS-R1a), a 7-transmembrane G-protein coupled receptor (GPCR) natively targeted by the endogenous ligand ghrelin. When bound to GHS-R1a, GHRP-2 stimulates the phospholipase C (PLC) signaling cascade, generating inositol trisphosphate (IP3) and diacylglycerol (DAG).
This intracellular pathway triggers the mobilization of intracellular calcium ions (Ca2+) from the endoplasmic reticulum into the cytoplasm within somatotropic cells. The intracellular calcium surge facilitates the exocytosis of pre-stored growth hormone granules. Preclinical studies suggest that GHRP-2 signaling is distinct from endogenous growth hormone-releasing hormone (GHRH) pathways, which operate predominantly via cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) signaling, demonstrating a synergistic effect when both receptor systems are activated simultaneously in pituitary tissue cultures.
In vitro data indicate that GHRP-2 acts directly on primary anterior pituitary cell cultures to induce concentration-dependent growth hormone release. Laboratory rodent models treated with GHRP-2 demonstrate rapid, transient spikes in systemic GH concentration, followed by secondary elevations in circulating insulin-like growth factor 1 (IGF-1) levels driven by hepatic gene transcription.
Additional research in non-human primates and rodent models reveals that GHRP-2 possesses mild adrenocorticotropic hormone (ACTH) and prolactin-releasing capabilities at high concentrations due to receptor cross-talk, though its affinity remains highest for somatotrope GHS-R1a targets. Researchers studying energy balance and metabolic regulation also utilize GHRP-2 to analyze ghrelin-mediated hypothalamic signaling, appetite-regulatory neuropeptide expression (such as NPY and AgRP), and somatotropic axis feedback loops.
Evaluating secretagogue pharmacology often involves comparative analysis across multiple synthetic hexapeptides and peptidomimetics. When designing comparative binding assays, researchers frequently contrast GHRP-2 against related compounds within the secretagogue class, such as GHRP-6, Ipamorelin, and non-peptide secretagogues.
Compared to GHRP-6, preclinical trials demonstrate that GHRP-2 exhibits higher potency for GHS-R1a activation with slightly less stimulation of ghrelin-induced orexigenic (appetite-stimulating) signaling pathways in brain tissue. Conversely, selective pentapeptides like Ipamorelin demonstrate greater receptor selectivity with virtually no transient elevations in ACTH or cortisol markers in animal models. When evaluating long-acting secretagogue dynamics, investigators often combine short-acting hexapeptides with GHRH analogs such as CJC-1295 to evaluate dual-receptor amplification dynamics in pituitary cultures.
Selecting a reliable supplier for GHRP-2 requires strict evaluation of analytical documentation. Research integrity depends upon purchasing compounds free from synthesis truncations, residual TFA (trifluoroacetic acid) salts, organic solvents, and microbial contaminants. High-performance liquid chromatography (RP-HPLC) chromatograms should display a clean, symmetrical main peak establishing an overall chemical purity of 99% or greater.
Electrospray ionization mass spectrometry (ESI-MS) reports must confirm the exact molecular mass of 818.0 Da (or [M+H]+ adduct mass) without secondary peaks signaling incomplete amino acid coupling during solid-phase peptide synthesis (SPPS). Furthermore, quantitative chromogenic LAL assays must verify that bacterial endotoxin levels remain under 0.05 EU/mg. Institutional buyers can review extended analytical documentation across our catalog via the main PX1 Research Reference Hub.
To maintain molecular integrity during laboratory handling, lyophilized GHRP-2 must be reconstituted using standard laboratory protocols. The powder should be brought to room temperature prior to opening the container to minimize moisture condensation. Solubilization should be performed using sterile, bacteriostatic water (0.9% benzyl alcohol) or phosphate-buffered saline (PBS, pH 7.4) depending on downstream assay compatibility.
Reconstitution should involve gentle swirling rather than vigorous vortexing, as mechanical shear stress can disrupt peptide tertiary interaction or induce aggregation. Once reconstituted into aqueous solution, aliquoting into single-use polypropylene microcentrifuge tubes is recommended to avoid destructive freeze-thaw cycles during longitudinal studies.
Lyophilized GHRP-2 remains stable at -20°C for up to 24 months when protected from light and desiccation. For long-term archive storage, maintaining samples at -80°C suppresses baseline hydrolysis and racemization. Unopened vials stored at controlled ambient temperatures (20°C to 25°C) maintain physical stability for short transits, but prolonged room-temperature storage causes rapid peptide degradation.
After reconstitution, aqueous GHRP-2 solutions should be stored under refrigeration at 2°C to 8°C and utilized within 21 to 28 days. Liquid aliquots stored at -20°C remain stable for up to 6 months. Exposure to direct ultraviolet light, alkaline pH conditions (> 8.0), or elevated temperatures accelerates deamidation and peptide bond cleavage.
For universities, contract research organizations (CROs), and biotechnology enterprises requiring large-volume batches for high-throughput screening, establishing a reliable procurement chain is critical. Batch-to-batch consistency ensures that baseline biological responses remain identical across multi-phase longitudinal studies.
PX1 Research provides institutional accounts with direct access to bulk quantities, customized lot sizing, and centralized access to analytical verification archives. Qualified institutional purchasers can review bulk volume tiers and request custom analytical documentation via our dedicated institutional wholesale access portal.
What is the purity specification of GHRP-2 provided by PX1 Research?
PX1 Research supplies GHRP-2 with a minimum purity rating of 99% as verified by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS) testing.
How is GHRP-2 validated for laboratory research use?
Every lot of GHRP-2 undergoes analytical testing in an ISO 17025 accredited laboratory. Each order includes access to a lot-specific Certificate of Analysis (COA) detailing HPLC purity profiles, ESI-MS mass verification, and endotoxin assay data.
What is the recommended reconstitution solvent for GHRP-2 in vitro assays?
GHRP-2 is typically reconstituted using sterile bacteriostatic water or sterile physiological saline (0.9% NaCl) under aseptic laboratory conditions. Choice of solvent depends on downstream assay requirements and cell line sensitivity.
What are the storage guidelines for lyophilized GHRP-2 powder?
Lyophilized GHRP-2 should be stored at -20°C upon receipt for optimal long-term stability. For extended preservation beyond 12 months, storage at -80°C in a desiccated environment is recommended.
Does GHRP-2 exhibit cross-reactivity with other pituitary receptors?
Preclinical studies demonstrate that while GHRP-2 has high selectivity for GHS-R1a, high concentrations in animal models may induce modest, transient secondary release of prolactin and ACTH.
How does GHRP-2 differ from GHRP-6 in preclinical studies?
Preclinical data show GHRP-2 possesses higher potency for growth hormone release per molar concentration than GHRP-6, while displaying lower comparative binding affinity for appetite-stimulating hypothalamic pathways.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in GMP-compliant facilities in the USA and shipped directly from fulfillment centers located in California and Arizona.
Can GHRP-2 be purchased for personal or medical use?
No. GHRP-2 supplied by PX1 Research is strictly designated for laboratory research, in vitro assays, and preclinical scientific study. It is not for human or veterinary use, therapy, or clinical consumption.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.